Seasonal Influenza Vaccination Update 2026

On 4 September 2026, the Ministry of Health and Communicable Diseases Agency said that influenza cases in Singapore had increased, while noting no indication that the infections were more severe than usual. Individuals at higher risk of severe influenza—including seniors aged 65 and above, children aged six months to under five years, and other vulnerable groups with underlying medical conditions—were encouraged to receive the 2026 southern-hemisphere seasonal influenza vaccine if they had not received it previously (MOH, 4 September 2026).

Interim approach while the northern-hemisphere vaccine is delayed

MOH said the 2026–2027 northern-hemisphere seasonal influenza vaccine was expected to become available across public and private healthcare providers in early to mid-October 2026, about two weeks later than usual. For people in the recommended groups, the northern-hemisphere vaccine is preferred when available. Those who have not previously received the 2026 southern-hemisphere vaccine may receive it for interim protection, but should still receive the northern-hemisphere vaccine when available, with a minimum eight-week interval between doses. People who already received the southern-hemisphere vaccine should wait for the northern-hemisphere vaccine as their next dose, also observing the eight-week minimum (MOH, 4 September 2026).

Access and respiratory-health boundaries

The 2026 southern-hemisphere vaccine remained available through healthcare providers. Appointments could be booked at participating CHAS general-practitioner clinics through vaccine.gov.sg/flu or at polyclinics; eligible adults aged 18 and above could also use participating retail pharmacies, while Healthier SG enrollees were encouraged to contact their enrolled clinic. Clinics were to reschedule affected appointments where necessary. The update is vaccination guidance, not a diagnosis or a statement that influenza infections are unusually severe; people with respiratory symptoms should follow MOH’s advice on staying home, masking when going out, and seeking medical attention when symptoms are severe, prolonged or worsening (MOH, 4 September 2026).

Recommended groups and interpretation boundaries

The update is targeted guidance for people at higher risk of severe influenza, not universal eligibility for an identical two-dose schedule. Seniors aged 65 and above, children aged six months to under five years, and people with underlying medical conditions are examples of the groups MOH highlights; the recommendation does not mean that every resident must receive both seasonal formulations immediately. The southern-hemisphere vaccine can provide interim protection for a person who has not received it, while the northern-hemisphere vaccine is preferred when it becomes available in early to mid-October 2026. The eight-week interval is a minimum spacing rule between the relevant doses, not evidence that the vaccines should be combined or that one dose determines a person's diagnosis. MOH also reported no indication that the increased activity represented unusually severe influenza infections. This remains a dated vaccination update, and later availability or clinical advice should be checked with healthcare providers (MOH, 4 September 2026).

Why the two formulations are discussed separately

MOH explains that influenza viruses circulate in Singapore throughout the year, with higher activity typically seen around May to August and December to March, corresponding approximately to seasonal peaks in the southern and northern hemispheres. The delayed northern-hemisphere formulation was expected to contain a two-strain change from the 2026 southern-hemisphere vaccine, following the World Health Organization's recommendation. The interim advice therefore balances immediate protection for a recommended-group person who has not yet received the southern-hemisphere dose against the preferred protection expected from the later northern-hemisphere dose. It is a time-limited public-health recommendation based on supply timing and strain composition, not a finding that the southern vaccine is universally ineffective or that everyone should repeat vaccination (MOH, 4 September 2026).